Edward M. Kaye
11 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 11 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell | $382K | Aug 18SEC filing | |
| Sell | $21K | Aug 18SEC filing | |
| Sell(10b5-1 plan) | $223K | Jun 1SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Edward M. Kaye's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 2 | ||
| 9 |
Alerts for Edward M. Kaye
Use this page
How to cite
Breakaway, Edward M. Kaye: Director at Cytokinetics (CYTK), Oct 16, 2026, getbreakaway.com/insiders/edward-m-kaye
Journalists: email support@getbreakaway.com for the data behind this page.